Catalent | CTLT - Trade Debtors


Catalent reported $760M in Trade Debtors for its fiscal quarter ending in September of 2024.



Trade Debtors Change Date
Agilent USD 1.49B 105M Sep/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Bruker USD 544.9M 6M Dec/2025
Centene USD 18.1B 5B Dec/2025
Charles River Laboratories USD 1.48B 715.2M Sep/2025
Cigna USD 31.71B 3.74B Sep/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 654M 8M Sep/2025
Elevance Health USD 21.54B 807M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
Hologic USD 584.2M 16.6M Dec/2025
Humana USD 3.27B 586M Dec/2025
Illumina USD 854M 125M Dec/2025
Intuitive Surgical USD 1.53B 267.6M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
J&J USD 17.61B 235M Sep/2025
Laboratory Of America USD 2.27B 11.5M Sep/2025
Lonza CHF 1.78B 55M Dec/2025
McKesson USD 28.21B 73M Dec/2025
Merck EUR 4.73B 182M Sep/2025
Merck USD 12.12B 596M Sep/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Quest Diagnostics USD 1.41B 48M Dec/2025
Repligen USD 148.97M 7.98M Sep/2025
Revvity USD 744.67M 64.41M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Supernus Pharmaceuticals USD 171.25M 30.42M Sep/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
UnitedHealth USD 23.02B 346M Dec/2025
Waters USD 828.84M 80.32M Dec/2025
West Pharmaceutical Services USD 574.4M 50.6M Dec/2025